Newsfeeds Archive - Page 2 of 4

2 minute read

Werewolf Therapeutics’ Cancer Drug Shows Promise in Early Study for Solid Tumors, Stock Soars

November 3, 9:26 AM

Werewolf Therapeutics Inc (NASDAQ: HOWL) released preliminary results from initial monotherapy dose-escalation cohorts of an ongoing Phase 1/1b trial of WTX-124 in patients with advanced or

HOWL

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

November 3, 9:05 AM

Gainers Novo Integrated Sciences (NASDAQ:NVOS) stock moved upwards by 25.6% to $0.32 during Friday’s pre-market session. The company’s…

ABCL

5 minute read

Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

November 2, 2:26 PM

Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.

ACLX

2 minute read

Why Roku Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

November 2, 8:08 AM

Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 39.7% to $0.1143 in pre-market trading after falling 17% on Wednesday. LumiraDX recently announced the receipt of the Nasdaq delisting determination.

ALBT

4 minute read

Werewolf Therapeutics To Present Clinical And Preclinical Data At The Society For Immunotherapy Of Cancer’s 38th Annual Meeting

By Benzinga Newsdesk

October 31, 9:11 AM

Interim, first-in-human clinical results from initial monotherapy dose-escalation cohorts in ongoing Phase 1/1b study of WTX-124 including safety and preliminary antitumor activity to be described in poster

HOWL